Intech Investment Management LLC Acquires New Shares in MiMedx Group, Inc. (NASDAQ:MDXG)

Intech Investment Management LLC acquired a new stake in MiMedx Group, Inc. (NASDAQ:MDXG) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 20,095 shares of the company’s stock, valued at approximately $119,000.

Several other institutional investors and hedge funds have also modified their holdings of MDXG. Allspring Global Investments Holdings LLC lifted its position in MiMedx Group by 1.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company’s stock worth $1,082,000 after acquiring an additional 1,822 shares during the last quarter. Hsbc Holdings PLC lifted its position in MiMedx Group by 7.3% during the 2nd quarter. Hsbc Holdings PLC now owns 34,343 shares of the company’s stock worth $233,000 after acquiring an additional 2,329 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in MiMedx Group by 7.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 45,623 shares of the company’s stock worth $316,000 after acquiring an additional 3,222 shares during the last quarter. Marshall Wace LLP lifted its position in MiMedx Group by 1.1% during the 2nd quarter. Marshall Wace LLP now owns 298,818 shares of the company’s stock worth $2,071,000 after acquiring an additional 3,223 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in MiMedx Group by 6.3% during the 3rd quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock worth $328,000 after acquiring an additional 3,292 shares during the last quarter. Institutional investors and hedge funds own 79.15% of the company’s stock.

MiMedx Group Stock Performance

NASDAQ:MDXG opened at $9.68 on Friday. The firm’s 50-day moving average is $7.28 and its 200-day moving average is $6.96. MiMedx Group, Inc. has a 52-week low of $5.47 and a 52-week high of $9.71. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 17.60 and a beta of 1.98.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $12.00.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.